Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled TrialMason, Malcolm D.; Clarke, Noel W.; James, Nicholas D.; Dearnaley, David P.; Spears, Melissa R.; Ritchie, Alastair W.S.; Attard, Gerhardt; Cross, William; Jones, Rob J.; Parker, Christopher C.; Russell, J. Martin; Thalmann, George N.; Schiavone, Francesca; Cassoly, Estelle; Matheson, David; Millman, Robin; Rentsch, Cyrill A.; Barber, Jim; Gilson, Clare; Ibrahim, Azman; Logue, John; Lydon, Anna; Nikapota, Ashok D.; O’Sullivan, Joe M.; Porfiri, Emilio; Protheroe, Andrew; Srihari, Narayanan Nair; Tsang, David; Wagstaff, John; Wallace, Jan; Walmsley, Catherine; Parmar, Mahesh K.B.; Sydes, Matthew R. · Journal of Clinical Oncology · 2017

Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.Kattan, J; Culine, S; Terrier-Lacombe, M J; Theodore, C; Droz, J P · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1993

Combination immunotherapy approachesDrake, C. G. · Annals of Oncology · 2012

Advances in immuno-oncologyEggermont, A.; Finn, O. · Annals of Oncology · 2012

Thanks to referees 2011Annals of Oncology · 2012

OsteosarcomaRitter, J.; Bielack, S. S. · Annals of Oncology · 2010

The role of chemotherapy in cholangiocarcinomaThongprasert, S. · Annals of Oncology · 2005

Spirituality in the cancer trajectoryPuchalski, C. M. · Annals of Oncology · 2012

New insights into pancreatic cancer biologyHidalgo, M. · Annals of Oncology · 2012